CECs (CD45–/CD146+/CD31+) counts, soluble VWF and VCAM-1 were statistically increased in diagnosis (MD-0) and gradually decreased during treatment. Conversely, EPCs (CD45–/CD34+/KDR+) levels were lower in MD-0, tending to increase throughout treatment. The gene discussed is PTPRC; the disease is Menkes disease.